Fungicidal activity of Candida albicans-induced murine lymphokine-activated killer cells against C. albicans hyphae in vitro

References

1. Abo T., Sugawara S., Amenomori A., Itoh H., Rikushi H., Moro I., Kumagai K. 1986; Selective phagocytosis of Gram-positive bacteria and interleukin-1-like factor production by a subpopulation of large granular lymphocytes. Journal of Immunology 136:3189–3197
   [Google Scholar]
2. Baccarini M., Blasi E., Puccetti P., Bistoni F. 1983; Phagocytic killing of Candida albicans by different murine effector cells. Sabouraudia 21:271–286
   [Google Scholar]
3. Baccarini M., Vecchiarelli A., Cassone A., Bistoni F. 1985; Killing of yeast, germ-tube and mycelial forms of Candida albicans by murine effectors as measured by a radiolabel release microassay. Journal of General Microbiology 131:505–513
   [Google Scholar]
4. Baccarini M., Bistoni F., Lohmann-Matthes M. L. 1986; Organ-associated macrophage precursor activity: isolation of candi-dacidal and tumoricidal effectors from the spleens of cyclophospha-mide-treated mice. Journal of Immunology 136:837–843
   [Google Scholar]
5. Beno D. W. A., Mathews H. L. 1990; Growth inhibition of Candida albicans by interleukin-2-induced lymph node cells. Cellular Immunology 128:89–100
   [Google Scholar]
6. Bistoni F., Baccarini M., Blasi E., Puccetti P., Marconi P., Garaci E. 1983; Correlation between in vivo and in vitro studies of the modulation of resistance to experimental Candida albicans infection by cyclophosphamide in mice. Infection and Immunity 40:46–51
   [Google Scholar]
7. Blasi E., Farinelli S., Varesio L., Bistoni F. 1990; Augmentation of GG2EE macrophage cell line-mediated anti-Candida activity by gamma interferon, tumor necrosis factor, and interleukin-1. Infection and Immunity 58:1073–1077
   [Google Scholar]
8. Blasi E., Mazzolla R., Barluzzi R., Mosci P., Bartoli A., Bistoni F. 1991; Intracerebral transfer of an in vitro established microglial cell line: local induction of a protective state against lethal challenge with Candida albicans . Journal of Neuroimmunology 32:249–257
   [Google Scholar]
9. Cerottini J. C., Brunner K. T. 1974; Cell-mediated cytotoxicity, allograft rejection, and tumor immunity. Advances in Immunology 18:67–129
   [Google Scholar]
10. Decker T., Lohmann-Matthes M. L., Baccarini M. 1986; Heterogeneous activity of immature and mature cells of the murine monocyte-macrophage lineage derived from different anatomical districts against yeast-phase Candida albicans . Infection and Immunity 54:477–486
    [Google Scholar]
11. Diamond R. D., Haudenschild C. C. 1981; Monocyte-mediated serum-independent damage to hyphal and pseudohyphal forms of Candida albicans in vitro . Journal of Clinical Investigation 67:173–182
    [Google Scholar]
12. Diamond R. D., Krzesicki R., Jao W. 1978; Damage to the pseudohyphal forms of Candida albicans by neutrophils in the absence of serum in vitro . Journal of Clinical Investigation 61:349–359
    [Google Scholar]
13. Djeu J. Y., Blanchard D. K. 1987; Regulation of human polymorphonuclear neutrophil (PMN) activity against Candida albicans by large granular lymphocytes via release of a PMN-activating factor. Journal of Immunology 139:2761–2767
    [Google Scholar]
14. Djeu J. Y., Blanchard D. K., Halkias D., Friedman H. 1986a; Growth inhibition of Candida albicans by human polymorphonuclear neutrophils: activation by interferon and tumour necrosis factor. Journal of Immunology 137:2980–2984
    [Google Scholar]
15. Djeu J. Y., Parapanissios A., Halkias D., Friedman H. 1986b; A rapid [³H]glucose incorporation assay for determination of lymphoid cell-mediated inhibition of Candida albicans growth. Journal of Immunological Methods 92:73–77
    [Google Scholar]
16. Fromtling R. A., Shadomy H. J. 1986; An overview of macrophage-fungal interactions. Mycopathologia 93:77–93
    [Google Scholar]
17. Haskill J. S., Proctor J. W., Yamamura Y. 1975; Host responses within solid tumors. I. Monocytic effector cells within rat sarcomas. Journal of the National Cancer Institute 54:387–393
    [Google Scholar]
18. Hasui M., Saikawa Y., Miura M., Takano N., Veno Y., Yachie A., Miyawaki T., Taniguchi N. 1989; Effector and precursor phenotypes of lymphokine-activated killer cells in mice with severe combined immunodeficiency (scid) and athymic (nude) mice. Cellular Immunology 120:230–239
    [Google Scholar]
19. Herberman R. B., Nunn M. E., La Vrin D. H. 1975; Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. International Journal of Cancer 16:216–229
    [Google Scholar]
20. Julius M. H., Simpson E., Herzenberg L. A. 1973; A rapid method for the isolation of functional thymus-derived lymphocytes. European Journal of Immunology 3:645–652
    [Google Scholar]
21. Kolotila M. P., Diamond R. D. 1990; Effects of neutrophils and in vitro oxidants on survival and phenotypic switching of Candida albicans WO-1. Infection and Immunity 58:1174–1179
    [Google Scholar]
22. Le For A. T., Eisenthal A., Rosenberg S. A. 1988; Heterogeneity of lymphokine-activated killer cells induced by IL-2. Separate lymphoid subpopulations lyse tumor, allogeneic blasts and modified syngeneic blasts. Journal of Immunology 140:4062–4071
    [Google Scholar]
23. Leijh P. C. J., van Barselaar M. T., van Furth R. 1977; Kinetics of phagocytosis and intracellular killing of Candida albicans by human granulocytes and monocytes. Infection and Immunity 17:313–325
    [Google Scholar]
24. Marconi P., Bistoni F., Boncio L., Bersani A., Bravi P., Pitzurra M. 1976; Utilizzazione di una soluzione salina ipertonica di cloruro di potassio (3 M KC1) per l'estrazione di antigeni solubili da Candida albicans . Annali Sclavo 18:61–66
    [Google Scholar]
25. Marconi P., Scaringi L., Tissi L., Boccanera M., Bistoni F., Bonmassar E., Cassone A. 1985; Induction of natural killer cell activity by inactivated Candida albicans in mice. Infection and Immunity 50:297–303
    [Google Scholar]
26. Mattia E., Cassone A. 1979; Inducibility of germ-tube formation in Candida albicans at different phases of yeast growth. Journal of General Microbiology 113:439–442
    [Google Scholar]
27. Odds F. C. 1988; Candida and Candidosis. , 2. London: Bailliere Tindall;
    [Google Scholar]
28. Saito M., Ichimura O., Kataoka M., Moriya W., Ueno K., Sugawara Y., Nanjo M., Ishida N. 1986; Pronounced antitumor effect of LAK-like cells induced in the peritoneal cavity of mice after intraperitoneal injection of OK-432, a killed streptococcal preparation. Cancer Immunology and Immunotherapy 22:161–168
    [Google Scholar]
29. Scaringi L., Marconi P., Boccanera M., Tissi L., Bistoni F., Cassone A. 1988; Cell wall components of Candida albicans as immunomodulators: induction of natural killer and macrophage-mediated peritoneal cell cytotoxicity in mice by mannoprotein and glucan fractions. Journal of General Microbiology 134:1265–1274
    [Google Scholar]
30. Scaringi L., Rosati E., Bistoni F., Cassone A., Marconi P. 1989; Lymphokine-activated killer (LAK)-like cells induced in mice after repeated intraperitoneal injections of inactivated Candida albicans . Journal of Chemotherapy 4:446–448
    [Google Scholar]
31. Scaringi L., Cornacchione P., Rosati E., Boccanera M., Cassone A., Bistoni F., Marconi P. 1990; Induction of LAK-like cells in the peritoneal cavity of mice by inactivated Candida albicans . Cellular Immunology 129:271–287
    [Google Scholar]
32. Scaringi L., Blasi E., Cornacchione P., Bietta C., Bistoni F. 1991; A rapid Candida albicans hyphal-form growth inhibition assay: determination of myelomonocytic-mediated antifungal activity. Mycoses 34:
    [Google Scholar]
33. Timonen T., Saksela E. 1980; Isolation of human NK cells by density gradient centrifugation. Journal of Immunological Methods 36:285–291
    [Google Scholar]
34. Vecchiarelli A., Dottorini M., Puliti M., Todisco T., Cenci E., Bistoni F. 1991; Defective candidacidal activity of alveolar macrophages and peripheral blood monocytes from patients with chronic obstructive pulmonary disease. American Review of Respiratory Disease 143:1049–1054
    [Google Scholar]